Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Smits

Showing results (211-220 of 295) with videos related to

Pageof 30
Sort By:
JACC. Cardiovascular Interventions|December 24, 2011
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomographyJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
JACC. Cardiovascular Interventions|January 21, 2017
Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV TrialKoen Teeuwen, René J van der Schaaf, Tom Adriaenssens, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
The Supreme Biodegradable Polymer DES in Acute and Chronic Coronary Syndromes: A PIONEER III SubstudyYasin Hussain, Shigeru Saito, Michael Curtis, et al.
The Journal of Invasive Cardiology|June 5, 2021
Percutaneous Coronary Intervention vs Medical Therapy for Coronary Lesions With Positive Fractional Flow Reserve (FFR) but Preserved Pressure-Bounded Coronary Flow Reserve (CFR): A Substudy of the Randomized Compare-Acute TrialJoost D E Haeck, Marcel Van't Veer, Frederik M Zimmermann, et al.
The Journal of Invasive Cardiology|January 11, 2005
Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesionsManiyal Vijayakumar, Gastón A Alfredo Rodriguez Granillo, Pedro A Lemos, et al.
Circulation|July 16, 2003
Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of casesPedro A Lemos, Francesco Saia, Jurgen M R Ligthart, et al.
JACC. Cardiovascular Interventions|September 24, 2011
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomographyJosep Gomez-Lara, Maria Radu, Salvatore Brugaletta, et al.
Circulation|November 25, 2010
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, John A Ormiston, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 27, 2020
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trialPieter C Smits, Chun Chin Chang, Bernard Chevalier, et al.
Lancet (London, England)|March 27, 2012
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysisTullio Palmerini, Giuseppe Biondi-Zoccai, Diego Della Riva, et al.
Pageof 30

Showing results (211-220 of 295) with videos related to

Sort By:
Pageof 30
JACC. Cardiovascular Interventions|December 24, 2011
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomographyJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
JACC. Cardiovascular Interventions|January 21, 2017
Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV TrialKoen Teeuwen, René J van der Schaaf, Tom Adriaenssens, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
The Supreme Biodegradable Polymer DES in Acute and Chronic Coronary Syndromes: A PIONEER III SubstudyYasin Hussain, Shigeru Saito, Michael Curtis, et al.
The Journal of Invasive Cardiology|June 5, 2021
Percutaneous Coronary Intervention vs Medical Therapy for Coronary Lesions With Positive Fractional Flow Reserve (FFR) but Preserved Pressure-Bounded Coronary Flow Reserve (CFR): A Substudy of the Randomized Compare-Acute TrialJoost D E Haeck, Marcel Van't Veer, Frederik M Zimmermann, et al.
The Journal of Invasive Cardiology|January 11, 2005
Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesionsManiyal Vijayakumar, Gastón A Alfredo Rodriguez Granillo, Pedro A Lemos, et al.
Circulation|July 16, 2003
Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of casesPedro A Lemos, Francesco Saia, Jurgen M R Ligthart, et al.
JACC. Cardiovascular Interventions|September 24, 2011
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomographyJosep Gomez-Lara, Maria Radu, Salvatore Brugaletta, et al.
Circulation|November 25, 2010
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, John A Ormiston, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 27, 2020
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trialPieter C Smits, Chun Chin Chang, Bernard Chevalier, et al.
Lancet (London, England)|March 27, 2012
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysisTullio Palmerini, Giuseppe Biondi-Zoccai, Diego Della Riva, et al.
Pageof 30